NCT03476642View on ClinicalTrials.gov

Distribution, Pharmacokinetics and Extent of Sensory Blockade in ESP Blocks

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 2, 2019

Primary Completion Date

February 19, 2024

Study Completion Date

March 31, 2024

Conditions
Distribution of Ropivacaine in Erector Spinae Plane Block
Interventions
DRUG

Ropivacaine

injection of 20mL of 0.5% Ropivacaine at the left or right T5 transverse process

DRUG

Epinephrine

injection of 20mL epinephrine in combination with ropivacaine at the left or right T5 transverse process

Trial Locations (1)

17033

Milton S.Hershey Medical center, Hershey

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER

NCT03476642 - Distribution, Pharmacokinetics and Extent of Sensory Blockade in ESP Blocks | Biotech Hunter | Biotech Hunter